NCT05369455

Brief Summary

Anesthesia will be induced in all patients using Fentanyl 1µg,propofol 2mg/kg and cisatracurium 0.15 mg/kg IV to facilitate endotracheal intubation, maintenance of anaesthesia afterward will be achieved by isoflurane1.5-2% in oxygen and air mixture, cisatracurium0.03 mg/kg. In both groups , ultrasound guided block will be performed by an experienced anesthesiologist who has no subsequent role in the study after induction of anesthesia and before starting of surgery in lateral position, sterilized and covered with sterile sheets. Aseptic precautions is taken by wearing sterile gowns and gloves A sterile preparation of the ultrasound probe is obligatory. Outcome parameters will be assessed by another anesthesiologist blinded to the groups of assignment. Group 1: group of ultrasound guided Erector spine plane block: Group 11: group of ultrasound guided Cauda block:

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 9, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2022

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 11, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

October 19, 2022

Status Verified

October 1, 2022

Enrollment Period

5 months

First QC Date

April 23, 2022

Last Update Submit

October 18, 2022

Conditions

Keywords

erector spinae -block-pediatric -lower limb

Outcome Measures

Primary Outcomes (1)

  • pain score

    pain will be assessed using Face, Legs, Activity, Cry, and Consolability (FLACC) or Numeric Rating Scale (NRS) scores

    in first 24 hours postoperatively

Secondary Outcomes (1)

  • total postoperative analgesic requirement

    first 24 hours postoperatively

Study Arms (2)

group 1

EXPERIMENTAL

group of ultrasound guided Erector spine plane block:

Procedure: erector spinae plane block

group 2

ACTIVE COMPARATOR

group of ultrasound guided Caudal block:

Procedure: ultrasound guided caudal block

Interventions

determine the efficacy and safety of ultra-sound guided erector spine plane block for providing postoperative analgesia in pediatric patients scheduled for lower limb surgeries as regard pain score , duration of analgesia and total postoperative analgesic requirement as a primary outcome as well as their safety as regard hemodynamics, adverse events local complications as secondary outcomes.

group 1

determine the efficacy and safety of ultra-sound guided caudal block for providing postoperative analgesia in pediatric patients scheduled for lower limb surgeries as regard pain score , duration of analgesia and total postoperative analgesic requirement as a primary outcome as well as their safety as regard hemodynamics, adverse events local complications as secondary outcomes.

group 2

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • aged 2-15years old,
  • classified by the American society of anesthesiologists as ASA I and II
  • who will be scheduled for elective lower limb surgery will be enrolled in our study.

You may not qualify if:

  • Parents refusal,
  • spine or chest wall deformity,
  • coagulation disorders, ,
  • known respiratory and cardiac disorders, renal or hepatic insufficiency
  • known allergy to study drugs, uncooperative patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University Hospitals

Tanta, 31511, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
neither investigator nor outcome assessors know which block patient had received
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

April 23, 2022

First Posted

May 11, 2022

Study Start

December 9, 2021

Primary Completion

May 10, 2022

Study Completion

July 30, 2022

Last Updated

October 19, 2022

Record last verified: 2022-10

Locations